The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...

A Durham company secured federal approval for its bioengineered tissue, which could become a revolutionary treatment for ...

Seeking treatment for those bulging, sometimes painful veins that pop up more often as you age? Here's what to know about ...

The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular ...

SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

Varicose veins require thorough assessment by vascular surgeons, especially using ultrasound, to determine the underlying ...

Millions of Americans suffer from vein disease and it’s not just a cosmetic issue. To better understand vein disease and what ...

Varicose capillaries are a common problem that impacts millions of individuals around the globe. These enlarged, twisted veins can be unsightly and also might ...

Humacyte's Symvess earns FDA approval as a first-in-class bioengineered vascular solution for urgent arterial injury repair ...

Highlights,FDA approves SYMVESS for urgent arterial injury treatment.,Clinical trials show high patency and low complication ...

YORK, Maine — York Hospital announced the expansion of its vascular and vein care services, with the addition of a new team ...